Royal KPN N.V. : The trend should regain control
Entry price | Target | Stop-loss | Potential |
---|
€3.32 |
€3.65 |
€3.15 |
+9.75% |
---|
Shares in Royal KPN N.V. show a positive technical chart pattern over the medium term. The timing to jump back on the rising trend seems good.
Strengths● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
● The group's high margin levels account for strong profits.
● The company is one of the best yield companies with high dividend expectations.
● Over the past four months, analysts' average price target has been revised upwards significantly.
● Historically, the company has been releasing figures that are above expectations.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company's earnings growth outlook lacks momentum and is a weakness.
● One of the major weak points of the company is its financial situation.
● The company's enterprise value to sales, at 3.66 times its current sales, is high.
● In relation to the value of its tangible assets, the company's valuation appears relatively high.
● The overall consensus opinion of analysts has deteriorated sharply over the past four months.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.